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	 Sea	level	 High	altitude	 P-value	
PaO2	(mmHg)	 91.8	±	4.2	 63.0	±	1.5	 <	0.001	
SaO2	(%)	 96.	0	±	0.4	 89.7	±	0.7	 <	0.001	
CaO2	(ml	l-1)	 180	±	14	 185	±	14	 0.036	
Haematocrit	(%)	 42.9	±	2.6	 45.3	±	3.2	 0.008	
[Hb]	(g	l-1)	 14.0	±	1.0	 15.4	±	1.3		 <	0.001	
PaO2,	O2	tension	in	arterial	blood;	SaO2,	arterial	oxyhaemoglobin	saturation;	CaO2,	arterial	479	
O2	content;	[Hb],	haemoglobin	concentration	in	arterial	blood.	480	
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Figure	legends	and	figures	482	
	483	
Figure	1.	Effect	of	high	altitude	exposure	on	resting	heart	rate	484	
Points	represent	individual	values	and	the	short	horizontal	lines	the	averages	at	SL	and	485	
HA,	respectively.	P-values	are	given	for	the	comparison	between	SL	and	HA	within	the	486	
respective	drug	condition.	SL,	sea	level;	HA,	high	altitude;	CONT,	control;	PROP,	487	
propranolol;	GLYC,	glycopyrrolate;	PROP+GLYC,	propranolol	and	glycopyrrolate	in	488	
combination.	489	
	490	
Figure	2.	Effect	of	high	altitude	exposure	on	haemodynamics	491	
Data	points	represent	means	±	S.D.	*p	<	0.05	HA	vs.	SL	within	the	same	drug	condition.	SL,	492	
sea	level;	HA,	high	altitude;	CONT,	control;	PROP,	propranolol;	GLYC,	glycopyrrolate;	493	
PROP+GLYC,	propranolol	and	glycopyrrolate	in	combination.	494	
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Figure	1.	498	
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Figure	2.	500	
